ZEPBOUND 2.5 mg/.5mL (Tirzepatide INJECTION, SOLUTION) 2.5 mg/.5mL

ZEPBOUND 2.5 mg/0.5mL is a subcutaneous injection solution containing tirzepatide. This medication is used for managing weight and supporting metabolic health. Learn more about its uses and effects.

Strength

2.5 mg/.5mL

Pack Size

4 SYRINGE in 1 CARTON (0002-2506-80) / .5 mL in 1 SYRINGE (0002-2506-01)

Manufacturer / TM Owner

Eli Lilly and Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ZEPBOUND 2.5 mg/0.5mL is primarily used for weight management and metabolic health support. It is often prescribed for individuals looking to achieve and maintain a healthy weight. The active ingredient, tirzepatide, works to regulate appetite and support metabolic functions. This medication is part of a broader treatment plan that includes diet and exercise.

Side Effects

Common effects of ZEPBOUND 2.5 mg/0.5mL may include reduced appetite and improved blood sugar levels. Some users may experience gastrointestinal discomfort, such as nausea or diarrhea, especially when starting the treatment. These effects vary among individuals and typically subside as the body adjusts to the medication.

Precautions & Warnings

ZEPBOUND 2.5 mg/0.5mL should be stored as directed and used under medical supervision. It is important to follow the prescribed dosage and administration instructions. Individuals with a history of pancreatitis or severe gastrointestinal issues should consult their healthcare provider before use. Always inform your healthcare provider about any existing medical conditions or allergies.

Avoid Interactions

ZEPBOUND 2.5 mg/0.5mL may interact with other medications, including those that affect blood sugar levels or appetite. It is advisable to avoid alcohol while using this medication, as it can enhance certain side effects. Always consult your healthcare provider before starting any new medication or supplement while using ZEPBOUND.

Frequently Asked Questions

ZEPBOUND 2.5 mg/0.5mL is used for weight management and metabolic health support.

ZEPBOUND 2.5 mg/0.5mL is administered via subcutaneous injection, typically in the abdomen, thigh, or upper arm.

Common side effects may include reduced appetite, nausea, and gastrointestinal discomfort.

It is important to consult your healthcare provider before using ZEPBOUND 2.5 mg/0.5mL with other medications.

ZEPBOUND 2.5 mg/0.5mL should be stored as directed, typically in a cool, dry place away from direct sunlight.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.